Business Update

Aethlon's device for treating infectious disease discussed in Homeland Defense Journal story

Published in Bioterrorism Week, January 15th, 2007

Aethlon Medical, Inc., (AEMD) a developer of therapeutic devices for infectious disease, announced that it is featured in a bioterrorism industry article published in The Homeland Defense Journal.

The article, titled "Do We Have The Medicines To Fight Terrorism'" reviews the current absence of treatments able to address bioterror threats and discusses the Aethlon Hemopurifier as a potential first-line countermeasure able to treat drug and vaccine resistant pathogens, including those genetically modified for increased virulence.

The article also discusses the role of Aethlon in the shift towards broad-spectrum therapeutics, and the potential of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Bioterrorism Week

Source: Bioterrorism Week (2007-01-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry